Toggle Dropdown
Announcements
Projects
Welcome guest
Log in
Loading
Loading...
https://www.medscape.com/viewarticle/979861
0
0
Rivaroxaban Outmatched by VKAs for AF in Rheumatic Heart Disease - Medscape
8/28/22 at 5:45pm
Organization
Medscape
Author
Patrice Wendling
Details
39 words
Summarize
Health Conditions
Health
Rivaroxaban
AF
VKAs
reduction
warfarin
Rheumatic Heart Disease
Medscape
INVICTUS
ESC 2022
A striking and unexpected reduction in death with the use of predominantly warfarin was just one of the many surprises delivered by the INVICTUS trial at ESC 2022.
Show more
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...